To demonstrate the safety and effectiveness of the Shockwave Reducer for treatment of patients with refractory angina pectoris treated with maximally tolerated…

Refractory Angina

~Estimated

~$10 – $8,750

Shockwave Medical, Inc.NCT05102019

Phase 2

Endocardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment: A 26-Week (With 26 Week Extension) Phase 2b Randomized, Multi-Center, Double-Blind, Sham Controlled Study to Evaluate Efficacy and Safety

This is a two-part study, comprised of an initial open-label run-in phase (Part 1) in a subset of 3 subjects to provide first data regarding safety, and feasib…

Refractory AnginaCoronary Artery Disease

~Estimated

~$10 – $8,750

XyloCor Therapeutics, Inc.NCT07048808